Calton & Associates, Inc. Horizon Therapeutics Public LTD CO Transaction History

Calton & Associates, Inc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 18, 2023	BUY	$62.39 - $113.8 $113,924 - $207,798	1,826 New	1,826 $0
Q2 2022 Jul 12, 2022	SELL	$79.4 - $116.36 $178,094 - $260,995	-2,243 Closed	0 $0
Q1 2022 Apr 12, 2022	SELL	$86.42 - $109.81 $114,852 - $145,937	-1,329 Reduced 37.21%	2,243 $236,000
Q4 2021 Jan 13, 2022	SELL	$98.56 - $119.91 $7,096 - $8,633	-72 Reduced 1.98%	3,572 $384,000
Q3 2021 Nov 05, 2021	SELL	$91.91 - $110.37 $2,757 - $3,311	-30 Reduced 0.82%	3,644 $399,000
Q2 2021 Aug 11, 2021	SELL	$86.24 - $95.92 $10,348 - $11,510	-120 Reduced 3.16%	3,674 $344,000
Q1 2021 May 03, 2021	BUY	$71.83 - $95.48 $272,523 - $362,251	3,794 New	3,794 $349,000
Q4 2020 Jan 25, 2021	SELL	$67.0 - $84.39 $195,104 - $245,743	-2,912 Closed	0 $0
Q3 2020 Oct 30, 2020	SELL	$55.23 - $79.93 $122,444 - $177,204	-2,217 Reduced 43.22%	2,912 $226,000
Q2 2020 Aug 10, 2020	BUY	$30.2 - $56.98 $154,895 - $292,250	5,129 New	5,129 $285,000
Q1 2020 Apr 30, 2020	SELL	$24.87 - $38.56 $216,642 - $335,896	-8,711 Closed	0 $0
Q4 2019 Feb 03, 2020	BUY	$25.43 - $36.67 $4,501 - $6,490	177 Added 2.07%	8,711 $315,000
Q3 2019 Nov 07, 2019	BUY	$23.0 - $27.97 $196,282 - $238,695	8,534 New	8,534 $232,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Calton & Associates, Inc., based on Form 13F filings with the SEC.

Stay updated on Calton & Associates, Inc. with notifications on news.